The total return over the past 12 months is +4.60% vs. +19.51% for the S&P 500. So far it's up -4.28% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +0.02% | (16.39%) | +0.33% | +5.15% | +9.42% | +14.61% |
| Total Return CAGR | +4.60% | (14.22%) | +2.46% | +7.59% | +11.76% | +16.93% |
| Revenue CAGR | +17.42% | +24.65% | +20.73% | +12.06% | +10.65% | +11.60% |
| Net Income CAGR | +26.16% | +30.32% | +23.08% | +13.97% | +13.86% | +16.23% |
| EPS CAGR | +15.33% | +27.16% | +19.59% | +13.88% | +15.01% | +17.60% |
| Free Cash Flow CAGR | (55.54%) | (20.29%) | (5.86%) | (0.72%) | +3.18% | +8.69% |
| Operating Cash Flow CAGR | (2.71%) | +15.97% | +17.74% | +11.57% | +11.37% | +13.33% |
| Dividends CAGR | (29.52%) | (8.26%) | +10.58% | +5.60% | +13.24% | +17.54% |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Novo Nordisk A/S (NVO)
| Year | Start price | End price | NVO Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $50.88 | $47.08 | (4.28%) | +10.13% | (14.41%) |
| 2025 | $86.02 | $50.88 | (39.22%) | +17.72% | (56.94%) |
| 2024 | $103.45 | $86.02 | (15.93%) | +24.89% | (40.82%) |
| 2023 | $67.67 | $103.45 | +54.79% | +26.19% | +28.60% |
| 2022 | $56.00 | $67.67 | +22.65% | (18.17%) | +40.82% |
| 2021 | $34.92 | $56.00 | +63.41% | +28.74% | +34.67% |
| 2020 | $28.94 | $34.92 | +23.29% | +18.37% | +4.92% |
| 2019 | $23.04 | $28.94 | +28.64% | +31.22% | (2.58%) |
| 2018 | $26.84 | $23.04 | (11.88%) | (4.56%) | (7.32%) |
| 2017 | $17.93 | $26.84 | +54.32% | +21.70% | +32.62% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
